Improving cancer care access for deaf and hard of hearing individuals.
Using technology-enhanced approaches to advance cancer health equity among diverse deaf, deafblind, and hard of hearing populations.
This study is looking to help deaf, deafblind, and hard of hearing people get better access to cancer information and services by training community health workers who know American Sign Language to guide them through cancer prevention and treatment.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Gallaudet University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-10909377 on NIH RePORTER |
What this research studies
This research aims to address the challenges faced by diverse deaf, deafblind, and hard of hearing (DDBHH) populations in accessing cancer health information and services. By employing American Sign Language (ASL)-proficient community health workers as cancer health navigators, the project seeks to enhance communication and understanding of cancer prevention and treatment. Utilizing advanced technology platforms like SNAP and REPEAT, the research will focus on training these navigators to effectively support DDBHH individuals in overcoming barriers to cancer care. The goal is to promote adherence to cancer screenings and reduce health disparities within this community.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are deaf, deafblind, or hard of hearing and use American Sign Language.
Not a fit: Patients who do not use American Sign Language or who do not identify as part of the DDBHH community may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve cancer care access and health outcomes for deaf and hard of hearing patients.
How similar studies have performed: Previous research has shown success in using community health workers to improve health outcomes in various populations, suggesting a promising approach for this specific community.
Where this research is happening
Washington, United States
- Gallaudet University — Washington, United States (Active)
Researchers
- Principal investigator: Kushalnagar, Poorna — Gallaudet University
- Study coordinator: Kushalnagar, Poorna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.